CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2017
Cash flows from operating activities:
Net earnings	$ 3,962,000,000	$ 5,031,000,000	$ 4,101,000,000
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	2,038,000,000	1,770,000,000	1,654,000,000
Gain on previously held equity interest	0	(337,000,000)	0
Deferred income taxes	100,000,000	(322,000,000)	(434,000,000)
Stock compensation expense	119,000,000	130,000,000	91,000,000
Equity earnings from equity method investments	(187,000,000)	(244,000,000)	(143,000,000)
Other	302,000,000	296,000,000	364,000,000
Changes in operating assets and liabilities:
Accounts receivable, net	(789,000,000)	(391,000,000)	(153,000,000)
Inventories	141,000,000	331,000,000	98,000,000
Other current assets	(112,000,000)	(22,000,000)	0
Trade accounts payable	954,000,000	1,352,000,000	1,684,000,000
Accrued expenses and other liabilities	(374,000,000)	287,000,000	(128,000,000)
Income taxes	(406,000,000)	694,000,000	44,000,000
Other non-current assets and liabilities	(154,000,000)	(311,000,000)	77,000,000
Net cash provided by operating activities	5,594,000,000	8,263,000,000	7,255,000,000
Cash flows from investing activities:
Additions to property, plant and equipment	(1,702,000,000)	(1,367,000,000)	(1,351,000,000)
Proceeds from sale leaseback transactions	3,000,000	0	444,000,000
Proceeds from sale of other assets	117,000,000	655,000,000	59,000,000
Business, investment and asset acquisitions, net of cash acquired	(741,000,000)	(4,793,000,000)	(88,000,000)
Other	16,000,000	4,000,000	93,000,000
Net cash used for investing activities	(2,307,000,000)	(5,501,000,000)	(843,000,000)
Cash flows from financing activities:
Net change in short-term debt with maturities of 3 months or less	536,000,000	586,000,000	33,000,000
Proceeds from debt	12,433,000,000	5,900,000,000	0
Payments of debt	(10,461,000,000)	(4,890,000,000)	(6,196,000,000)
Stock purchases	(4,160,000,000)	(5,228,000,000)	(5,220,000,000)
Proceeds related to employee stock plans	174,000,000	174,000,000	217,000,000
Cash dividends paid	(1,643,000,000)	(1,739,000,000)	(1,723,000,000)
Other	75,000,000	(98,000,000)	(45,000,000)
Net cash used for financing activities	(3,047,000,000)	(5,295,000,000)	(12,934,000,000)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(9,000,000)	11,000,000	26,000,000
Changes in cash, cash equivalents and restricted cash
Net increase (decrease) in cash, cash equivalents, and restricted cash	232,000,000	(2,522,000,000)	(6,496,000,000)
Cash, cash equivalents and restricted cash at beginning of period	975,000,000	3,496,000,000	9,992,000,000
Cash, cash equivalents and restricted cash at end of period	$ 1,207,000,000	$ 975,000,000	$ 3,496,000,000